Wilmington, DE -- (SBWIRE) -- 08/26/2013 -- Equity Profile Report expands its NYSE Active Stock Weekly Watch List adding Neuralstem, Inc. (NYSE:CUR) and B2Gold Corp. (NYSE:BTG).
Neuralstem, Inc. (NYSE:CUR) a biopharmaceutical company that focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds is currently down (-1.75%) on 645,534 shares traded. Neuralstem, Inc. (NYSE:CUR) is currently down (-13.27%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Active Stock Watch List.
Click Here to find out what other Investors are saying about Neuralstem, Inc. (NYSE:CUR)
B2Gold Corp. (NYSE:BTG) a company that engages in the exploration and development of mineral properties in Nicaragua, Colombia, Namibia, and Uruguay is currently up (+0.17%) on 968,806 shares traded after B2Gold Corp. announced the closing of its previously announced offering of US$225 million aggregate principal amount of its 3.25% convertible senior subordinated notes due October 1, 2018 to qualified institutional buyers in accordance with Rule 144A under the U.S. Securities Act of 1933, as amended. B2Gold Corp. (NYSE:BTG) is currently up (+66.85%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Active Stock Watch List.
Click Here to find out what other Investors are saying about B2Gold Corp. (NYSE:BTG)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)